Prevention of heterotopic ossification after total hip replacement - A prospective comparison of indomethacin and salmon calcitonin in 60 patients


Creative Commons License

Gunal I., Hazer B., Seber S., Gokturk E., Turgut A., KÖSE N.

ACTA ORTHOPAEDICA SCANDINAVICA, vol.72, no.5, pp.467-469, 2001 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 72 Issue: 5
  • Publication Date: 2001
  • Doi Number: 10.1080/000164701753532781
  • Journal Name: ACTA ORTHOPAEDICA SCANDINAVICA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.467-469
  • Dokuz Eylül University Affiliated: No

Abstract

We did a prospective consecutive study of prophylaxis for heterotopic ossification (HO) comparing indomethacin (100 mg/day) and salmon calcitonin (3 MRC-U/kg/day) for 14 days. Each group consisted of 30 patients. 19 patients in the indomethacin group and 2 in the calcitonin group developed HO. We conclude that use of calcitonin in the prophylaxis of HO after total hip replacement is more effective than indomethacin.